The insulin resistance seen in NAFLD, diabetes and obesity results in compensatory systemic hyperinsulinaemia and increased Insulin-like Growth Factor-1 (IGF-1) production in the liver [91, 92]. This evidence concerns the gene IGF1 and metabolic dysfunction-associated steatotic liver disease.